吡格列酮-话题@MedSci

#吡格列酮#

57篇内容 | 2864人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1448007, encodeId=4e7a144800e75, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=JAMA Neurol：吡格列酮可降低缺血性卒中或短暂性脑缺血后复发风险, objectType=article, longId=113254, objectId=180d1132547c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=180d1132547c, replyNumber=0, likeNumber=75, createdTime=2017-09-21, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=180d1132547c, moduleTitle=JAMA Neurol：吡格列酮可降低缺血性卒中或短暂性脑缺血后复发风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=180d1132547c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448025, encodeId=f6db144802532, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=Lancet diabetes endo：对于二甲双胍控制不佳的2型糖尿病患者，添加吡格列酮或磺脲类药物对患者心血管事件发生概率的影响对比。, objectType=article, longId=112793, objectId=c7ba112e93e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7ba112e93e9, replyNumber=0, likeNumber=108, createdTime=2017-09-15, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7ba112e93e9, moduleTitle=Lancet diabetes endo：对于二甲双胍控制不佳的2型糖尿病患者，添加吡格列酮或磺脲类药物对患者心血管事件发生概率的影响对比。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7ba112e93e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448006, encodeId=1cf61448006d1, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=【关注2017EASD】TOSCA IT研究：磺脲与吡格列酮孰优孰劣？, objectType=article, longId=112534, objectId=c0db1125344f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0db1125344f, replyNumber=0, likeNumber=98, createdTime=2017-09-12, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0db1125344f, moduleTitle=【关注2017EASD】TOSCA IT研究：磺脲与吡格列酮孰优孰劣？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0db1125344f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448005, encodeId=89f81448005b4, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=Diabetes Care：格列净vs.吡格列酮—对合并非酒精性脂肪肝的2型糖尿病的作用！, objectType=article, longId=107171, objectId=034c10e17196, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=034c10e17196, replyNumber=0, likeNumber=70, createdTime=2017-08-01, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=034c10e17196, moduleTitle=Diabetes Care：格列净vs.吡格列酮—对合并非酒精性脂肪肝的2型糖尿病的作用！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=034c10e17196)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448004, encodeId=ea4f1448004e7, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=Diabetes Obes Metab：老年2型糖尿病患者采用吡格列酮与其他治疗发生膀胱癌的风险比较！, objectType=article, longId=104140, objectId=75b010414099, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75b010414099, replyNumber=0, likeNumber=52, createdTime=2017-07-02, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75b010414099, moduleTitle=Diabetes Obes Metab：老年2型糖尿病患者采用吡格列酮与其他治疗发生膀胱癌的风险比较！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75b010414099)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448003, encodeId=47b51448003ec, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=Circulation：吡格列酮能否降低缺血性卒中或短暂缺血发作后的ACS风险？, objectType=article, longId=101652, objectId=5075101652cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5075101652cf, replyNumber=0, likeNumber=75, createdTime=2017-06-14, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5075101652cf, moduleTitle=Circulation：吡格列酮能否降低缺血性卒中或短暂缺血发作后的ACS风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5075101652cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448002, encodeId=3701144800276, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=Circulation：吡格列酮对缺血性卒中或TIA后的心脏作用, objectType=article, longId=90508, objectId=09539050854, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09539050854, replyNumber=0, likeNumber=0, createdTime=2017-03-04, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09539050854, moduleTitle=Circulation：吡格列酮对缺血性卒中或TIA后的心脏作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=09539050854)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448001, encodeId=3c4814480010c, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=Diabetes Care：艾塞那肽与吡格列酮联合或可替代胰岛素治疗2型糖尿病（Qatar研究）, objectType=article, longId=87796, objectId=ceef8e796aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ceef8e796aa, replyNumber=0, likeNumber=69, createdTime=2017-01-20, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ceef8e796aa, moduleTitle=Diabetes Care：艾塞那肽与吡格列酮联合或可替代胰岛素治疗2型糖尿病（Qatar研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ceef8e796aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448000, encodeId=aad2144800050, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=Stroke：吡格列酮可以进行卒中二级预防, objectType=article, longId=85071, objectId=ae27850e1b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae27850e1b1, replyNumber=0, likeNumber=81, createdTime=2016-12-23, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae27850e1b1, moduleTitle=Stroke：吡格列酮可以进行卒中二级预防, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae27850e1b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447999, encodeId=433c144e99982, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=洗白了！吡格列酮的使用与前列腺癌的发病风险增加无关！, objectType=article, longId=84692, objectId=f7a08469251, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7a08469251, replyNumber=0, likeNumber=74, createdTime=2016-12-20, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7a08469251, moduleTitle=洗白了！吡格列酮的使用与前列腺癌的发病风险增加无关！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7a08469251)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447998, encodeId=7589144e9985f, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=Diabetes Care：吡格列酮，可同时预防糖尿病和心血管疾病, objectType=article, longId=78144, objectId=d8e6e8144df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8e6e8144df, replyNumber=0, likeNumber=67, createdTime=2016-09-23, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8e6e8144df, moduleTitle=Diabetes Care：吡格列酮，可同时预防糖尿病和心血管疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8e6e8144df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447997, encodeId=57ad144e997d0, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=细数吡格列酮与糖尿病相关数据, objectType=article, longId=75203, objectId=c0c9e520310, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0c9e520310, replyNumber=0, likeNumber=86, createdTime=2016-08-17, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0c9e520310, moduleTitle=细数吡格列酮与糖尿病相关数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0c9e520310)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447996, encodeId=c639144e9969d, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=Ann Intern Med：吡格列酮可改善NASH，阻止2型糖尿病患者的疾病进展, objectType=article, longId=71701, objectId=37a1e1701c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37a1e1701c3, replyNumber=0, likeNumber=83, createdTime=2016-06-29, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37a1e1701c3, moduleTitle=Ann Intern Med：吡格列酮可改善NASH，阻止2型糖尿病患者的疾病进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37a1e1701c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447995, encodeId=be9f144e99563, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=Ann Intern Med：吡格列酮可安全有效治疗同时伴有脂肪性肝病和糖尿病的患者, objectType=article, longId=71466, objectId=c86de1466c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c86de1466c9, replyNumber=0, likeNumber=72, createdTime=2016-06-24, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c86de1466c9, moduleTitle=Ann Intern Med：吡格列酮可安全有效治疗同时伴有脂肪性肝病和糖尿病的患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c86de1466c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447994, encodeId=c316144e9946d, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=ADA 2016：吡格列酮可降低伴卒中史的前驱糖尿病患者的糖尿病风险, objectType=article, longId=71171, objectId=908ae117130, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=908ae117130, replyNumber=0, likeNumber=75, createdTime=2016-06-19, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=908ae117130, moduleTitle=ADA 2016：吡格列酮可降低伴卒中史的前驱糖尿病患者的糖尿病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=908ae117130)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447993, encodeId=63a3144e993aa, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=NEJM：缺血性中风或TIA后接受吡格列酮治疗可降低中风或心肌梗死的发生风险, objectType=article, longId=66295, objectId=f0a066295b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0a066295b8, replyNumber=0, likeNumber=71, createdTime=2016-04-10, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0a066295b8, moduleTitle=NEJM：缺血性中风或TIA后接受吡格列酮治疗可降低中风或心肌梗死的发生风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0a066295b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447992, encodeId=03db144e9927d, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=BMJ：2型糖尿病患者服用吡格列酮增加膀胱癌风险, objectType=article, longId=65765, objectId=32e765e6591, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32e765e6591, replyNumber=0, likeNumber=82, createdTime=2016-04-01, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32e765e6591, moduleTitle=BMJ：2型糖尿病患者服用吡格列酮增加膀胱癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32e765e6591)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447991, encodeId=f983144e991f6, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=JCEM：吡格列酮预防糖尿病，可以停药吗（ACT NOW研究）？, objectType=article, longId=65654, objectId=bf2065654e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf2065654e7, replyNumber=0, likeNumber=76, createdTime=2016-03-29, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf2065654e7, moduleTitle=JCEM：吡格列酮预防糖尿病，可以停药吗（ACT NOW研究）？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf2065654e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447990, encodeId=124f144e99092, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=吡格列酮：老枝逢春吐新芽，可减少近期发生卒中或TIA, objectType=article, longId=64385, objectId=3fb96438534, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3fb96438534, replyNumber=0, likeNumber=75, createdTime=2016-03-08, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3fb96438534, moduleTitle=吡格列酮：老枝逢春吐新芽，可减少近期发生卒中或TIA, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3fb96438534)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447989, encodeId=1763144e989ee, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=NEJM：吡格列酮治疗缺血性卒中或短暂性脑缺血发作效果一般, objectType=article, longId=63406, objectId=761d63406e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=761d63406e6, replyNumber=0, likeNumber=41, createdTime=2016-02-20, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=761d63406e6, moduleTitle=NEJM：吡格列酮治疗缺血性卒中或短暂性脑缺血发作效果一般, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=761d63406e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

吡格列酮

2020-05-29

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

JAMA Neurol：吡格列酮可降低缺血性卒中或短暂性脑缺血后复发风险

2017-09-21

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

Lancet diabetes endo：对于二甲双胍控制不佳的2型糖尿病患者，添加吡格列酮或磺脲类药物对患者心血管事件发生概率的影响对比。

2017-09-15

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

【关注2017EASD】TOSCA IT研究：磺脲与吡格列酮孰优孰劣？

2017-09-12

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

Diabetes Care：格列净vs.吡格列酮—对合并非酒精性脂肪肝的2型糖尿病的作用！

2017-08-01

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

Diabetes Obes Metab：老年2型糖尿病患者采用吡格列酮与其他治疗发生膀胱癌的风险比较！

2017-07-02

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

Circulation：吡格列酮能否降低缺血性卒中或短暂缺血发作后的ACS风险？

2017-06-14

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

Circulation：吡格列酮对缺血性卒中或TIA后的心脏作用

2017-03-04

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

Diabetes Care：艾塞那肽与吡格列酮联合或可替代胰岛素治疗2型糖尿病（Qatar研究）

2017-01-20

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

Stroke：吡格列酮可以进行卒中二级预防

2016-12-23

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

洗白了！吡格列酮的使用与前列腺癌的发病风险增加无关！

2016-12-20

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

Diabetes Care：吡格列酮，可同时预防糖尿病和心血管疾病

2016-09-23

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

细数吡格列酮与糖尿病相关数据

2016-08-17

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

Ann Intern Med：吡格列酮可改善NASH，阻止2型糖尿病患者的疾病进展

2016-06-29

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

Ann Intern Med：吡格列酮可安全有效治疗同时伴有脂肪性肝病和糖尿病的患者

2016-06-24

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

ADA 2016：吡格列酮可降低伴卒中史的前驱糖尿病患者的糖尿病风险

2016-06-19

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

NEJM：缺血性中风或TIA后接受吡格列酮治疗可降低中风或心肌梗死的发生风险

2016-04-10

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

BMJ：2型糖尿病患者服用吡格列酮增加膀胱癌风险

2016-04-01

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

JCEM：吡格列酮预防糖尿病，可以停药吗（ACT NOW研究）？

2016-03-29

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

吡格列酮：老枝逢春吐新芽，可减少近期发生卒中或TIA

2016-03-08

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

NEJM：吡格列酮治疗缺血性卒中或短暂性脑缺血发作效果一般

2016-02-20

科室
- - 订阅+
  - 更多科室
工具
服务